Pathfinder Cell Therapy Inc
OTC:PFND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pathfinder Cell Therapy Inc
OTC:PFND
|
US |
|
Educational Development Corp
NASDAQ:EDUC
|
US |
|
H
|
HMCIB No.5 Special Purpose Acquisition Co
KOSDAQ:353060
|
KR |
|
G
|
G-Able PCL
SET:GABLE
|
TH |
|
M
|
MK Electron
KOSDAQ:033160
|
KR |
|
Altenergy Acquisition Corp
OTC:AEAE
|
US |
|
D
|
Dust SA
WSE:THD
|
PL |
|
T
|
TRC Construction PCL
SET:TRC
|
TH |
|
H
|
Hua Hsu Advanced Technology Co Ltd
TPEX:6682
|
TW |
|
Asia Orient Holdings Ltd
F:ASD1
|
HK |
|
Tungsten Mining NL
ASX:TGN
|
AU |
|
UCA AG
F:UCA1
|
DE |
|
S
|
Siddhi Acquisition Corp
NASDAQ:SDHI
|
US |
Shareholder Yield
Current shareholder yield for PFND is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
PFND Price
Pathfinder Cell Therapy Inc
| Average Annual Return | -48.75% |
| Standard Deviation of Annual Returns | 56.33% |
| Max Drawdown | -100% |
| Market Capitalization | 667 USD |
| Shares Outstanding | 6 670 000 |
| Percentage of Shares Shorted |
N/A
|
